Literature DB >> 22488007

In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study.

Gavin C K W Koh1, Alexander P J Vlaar, Jorrit J Hofstra, H Katrien de Jong, Samuel van Nierop, Sharon J Peacock, W Joost Wiersinga, Marcus J Schultz, Nicole P Juffermans.   

Abstract

OBJECTIVES: Patients with diabetes mellitus form 23%-30% of published cohorts of critically ill patients. Conflicting published evidence links diabetes mellitus to both higher and lower mortality. Other cohort studies suggest that diabetes mellitus protects against acute lung injury. We hypothesized that diabetes mellitus is an independent risk factor for mortality. We further hypothesized that diabetes mellitus is a risk factor for cardiac overload and not for acute lung injury.
DESIGN: Retrospective cohort study.
SETTING: The intensive care unit of a tertiary referral hospital. PATIENTS: From November 1, 2004, to October 1, 2007, a cohort of patients admitted ≥48 hrs to the intensive care unit.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 2,013 patients, 317 had diabetes mellitus. Ninety-day mortality was higher in the diabetes mellitus patients compared to patients without diabetes mellitus (hazard ratio 1.53, 95% confidence interval 1.29-1.80). This association strengthened after adjusting for confounders and for medication (hazard ratio 1.53, 95% confidence interval 1.07-2.17).We found no association between diabetes mellitus and acute lung injury (relative risk ratio 1.01, 95% confidence interval 0.78-1.32; adjusted relative risk ratio 0.99, 95% confidence interval 0.75-1.31), but diabetes mellitus was a risk factor for cardiac overload (relative risk ratio 1.91, 95% confidence interval 1.30-2.81; adjusted relative risk ratio 1.45, 95% confidence interval 0.97-2.18). Statins were associated with both a reduced risk of mortality (hazard ratio 0.74, 95% confidence interval 0.63-0.87; adjusted hazard ratio 0.53, 95% confidence interval 0.44-0.64) and a decreased risk of developing acute lung injury (relative risk ratio 0.71, 95% confidence interval 0.56-0.89; adjusted relative risk ratio 0.61, 95% confidence interval 0.47-0.79).
CONCLUSIONS: Diabetes mellitus is an independent risk factor for mortality in critically ill patients and failure to adjust for statins underestimates the size of this association. Diabetes mellitus is not associated with acute lung injury but is associated with cardiac overload. A diagnosis of cardiac overload excludes a diagnosis of acute lung injury. Investigators who do not account for cardiac overload as a competing alternative outcome may therefore falsely conclude that diabetes mellitus protects from acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488007      PMCID: PMC3379571          DOI: 10.1097/CCM.0b013e31824e1696

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  34 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Data, design, and background knowledge in etiologic inference.

Authors:  J M Robins
Journal:  Epidemiology       Date:  2001-05       Impact factor: 4.822

Review 3.  Defining and improving data quality in medical registries: a literature review, case study, and generic framework.

Authors:  Danielle G T Arts; Nicolette F De Keizer; Gert-Jan Scheffer
Journal:  J Am Med Inform Assoc       Date:  2002 Nov-Dec       Impact factor: 4.497

4.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

5.  Diabetes does not influence selected clinical outcomes in critically ill burn patients.

Authors:  Chaitanya K Dahagam; Alejandra Mora; Steven E Wolf; Charles E Wade
Journal:  J Burn Care Res       Date:  2011 Mar-Apr       Impact factor: 1.845

6.  Diabetic patients have a decreased incidence of acute respiratory distress syndrome.

Authors:  M Moss; D M Guidot; K P Steinberg; G F Duhon; P Treece; R Wolken; L D Hudson; P E Parsons
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

7.  Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.

Authors:  Hollis R O'Neal; Tatsuki Koyama; Elizabeth A S Koehler; Edward Siew; Blake R Curtis; Richard D Fremont; Addison K May; Gordon R Bernard; Lorraine B Ware
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

8.  Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry.

Authors:  Daniëlle Arts; Nicolette de Keizer; Gert-Jan Scheffer; Evert de Jonge
Journal:  Intensive Care Med       Date:  2002-04-13       Impact factor: 17.440

Review 9.  The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis.

Authors:  Surinder Janda; Aaron Young; J Mark Fitzgerald; Mahyar Etminan; John Swiston
Journal:  J Crit Care       Date:  2010-04-22       Impact factor: 3.425

10.  Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis.

Authors:  Gavin C K W Koh; Rapeephan R Maude; M Fernanda Schreiber; Direk Limmathurotsakul; W Joost Wiersinga; Vanaporn Wuthiekanun; Sue J Lee; Weera Mahavanakul; Wipada Chaowagul; Wirongrong Chierakul; Nicholas J White; Tom van der Poll; Nicholas P J Day; Gordon Dougan; Sharon J Peacock
Journal:  Clin Infect Dis       Date:  2011-02-03       Impact factor: 9.079

View more
  15 in total

1.  Diabetes increases pancreatitis induced systemic inflammation but has little effect on inflammation and cell death in the lung.

Authors:  Dietmar Zechner; Marie Spitzner; Tassilo Müller-Graff; Brigitte Vollmar
Journal:  Int J Exp Pathol       Date:  2014-11-17       Impact factor: 1.925

2.  Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS.

Authors:  Liang Luo; Ciara M Shaver; Zhiguo Zhao; Tatsuki Koyama; Carolyn S Calfee; Julie A Bastarache; Lorraine B Ware
Journal:  Chest       Date:  2016-09-20       Impact factor: 9.410

3.  Role of diabetes in the development of acute respiratory distress syndrome.

Authors:  Shun Yu; David C Christiani; B Taylor Thompson; Ednan K Bajwa; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

4.  Statin use and risk of delirium in the critically ill.

Authors:  Valerie J Page; Daniel Davis; Xiao B Zhao; Samuel Norton; Annalisa Casarin; Thomas Brown; E Wesley Ely; Daniel F McAuley
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

5.  Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury.

Authors:  Dilip Shah; Freddy Romero; Michelle Duong; Nadan Wang; Bishnuhari Paudyal; Benjamin T Suratt; Caleb B Kallen; Jianxin Sun; Ying Zhu; Kenneth Walsh; Ross Summer
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

6.  Prognostic factors in the acute respiratory distress syndrome.

Authors:  Wei Chen; Lorraine B Ware
Journal:  Clin Transl Med       Date:  2015-07-02

7.  Inhaled aerosolized insulin ameliorates hyperglycemia-induced inflammatory responses in the lungs in an experimental model of acute lung injury.

Authors:  Wei Fan; Koichi Nakazawa; Shinya Abe; Miori Inoue; Masanobu Kitagawa; Noriyuki Nagahara; Koshi Makita
Journal:  Crit Care       Date:  2013-04-28       Impact factor: 9.097

8.  Outcomes of diabetic and nondiabetic patients undergoing general and vascular surgery.

Authors:  Stephen Serio; John M Clements; Dawn Grauf; Aziz M Merchant
Journal:  ISRN Surg       Date:  2013-12-26

9.  Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre-existing diabetes: a meta-analysis.

Authors:  Wan-Jie Gu; You-Dong Wan; Hong-Tao Tie; Quan-Cheng Kan; Tong-Wen Sun
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy.

Authors:  Aude Carillion; Sarah Feldman; Na Na; Matthieu Biais; Wassila Carpentier; Aurélie Birenbaum; Nicolas Cagnard; Xavier Loyer; Dominique Bonnefont-Rousselot; Stéphane Hatem; Bruno Riou; Julien Amour
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.